Liquid Embolic Market by Product Type, End-Users, and Geography (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032
Description
Persistence Market Research has recently released a comprehensive report on the worldwide market for liquid embolic agents. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global liquid embolic market from 2025 to 2032.
Key Insights:
Liquid embolic agents play a crucial role in interventional radiology and neurosurgery for the treatment of vascular abnormalities such as arteriovenous malformations (AVMs), aneurysms, and tumors. These agents are injected into the vascular system to occlude abnormal blood vessels, preventing hemorrhage and reducing blood flow to pathological areas. The liquid embolic market caters primarily to hospitals, specialty clinics, and surgical centers, offering various products such as ethylene vinyl alcohol copolymer (EVOH)-based agents, cyanoacrylates, and other polymer-based embolics. Market growth is driven by the rising prevalence of cerebrovascular diseases, increasing adoption of minimally invasive procedures, and advancements in embolic materials that improve safety and efficacy.
Market Growth Drivers:
The global liquid embolic market is propelled by several key factors, including the increasing incidence of neurovascular disorders and growing preference for minimally invasive treatment options over conventional surgery. The rise in demand for embolization procedures in oncology, especially for tumor devascularization, further drives market expansion. Technological innovations, such as the development of newer polymer formulations and radiopaque embolics, offer enhanced precision during procedures and better clinical outcomes. Furthermore, the increasing availability of skilled interventional radiologists and growing healthcare infrastructure in emerging markets create new growth avenues for market players.
Market Restraints:
Despite promising growth prospects, the liquid embolic market faces challenges related to high treatment costs, procedural complexities, and regulatory hurdles. The expensive nature of embolic agents and associated procedural devices limits adoption in cost-sensitive regions. Additionally, the risk of complications such as non-target embolization and the need for specialized training constrain wider usage. Regulatory approval processes for novel embolic materials can be lengthy and stringent, impacting time-to-market for new products.
Market Opportunities:
The liquid embolic market presents significant growth opportunities driven by ongoing research in novel embolic formulations, expansion into emerging markets, and increasing use in peripheral vascular interventions. The integration of digital imaging and navigation technologies enhances procedural accuracy and safety, opening new avenues for market growth. Strategic partnerships between device manufacturers and healthcare providers, along with focused investments in clinical trials and education programs, are essential to leverage these opportunities and sustain competitive advantage in this evolving market.
Key Questions Answered in the Report:
These companies invest heavily in R&D to develop novel embolic materials with enhanced biocompatibility, visibility, and ease of delivery. Collaborations with healthcare institutions and training programs for interventional specialists aid in increasing adoption rates. Moreover, emphasis on clinical trials and regulatory approvals supports market credibility and drives growth in various geographies.
Key Companies Profiled:
The liquid embolic market encompasses a diverse range of products, technologies, applications, and end-user segments, addressing various vascular disorders and patient populations.
By Product
Please Note: It will take 5 business days to complete the report upon order confirmation.
Key Insights:
- Liquid Embolic Market Size (2025E): USD 384.2 Million
- Projected Market Value (2032F): USD 703.6 Million
- Global Market Growth Rate (CAGR 2025 to 2032): 9.0%
Liquid embolic agents play a crucial role in interventional radiology and neurosurgery for the treatment of vascular abnormalities such as arteriovenous malformations (AVMs), aneurysms, and tumors. These agents are injected into the vascular system to occlude abnormal blood vessels, preventing hemorrhage and reducing blood flow to pathological areas. The liquid embolic market caters primarily to hospitals, specialty clinics, and surgical centers, offering various products such as ethylene vinyl alcohol copolymer (EVOH)-based agents, cyanoacrylates, and other polymer-based embolics. Market growth is driven by the rising prevalence of cerebrovascular diseases, increasing adoption of minimally invasive procedures, and advancements in embolic materials that improve safety and efficacy.
Market Growth Drivers:
The global liquid embolic market is propelled by several key factors, including the increasing incidence of neurovascular disorders and growing preference for minimally invasive treatment options over conventional surgery. The rise in demand for embolization procedures in oncology, especially for tumor devascularization, further drives market expansion. Technological innovations, such as the development of newer polymer formulations and radiopaque embolics, offer enhanced precision during procedures and better clinical outcomes. Furthermore, the increasing availability of skilled interventional radiologists and growing healthcare infrastructure in emerging markets create new growth avenues for market players.
Market Restraints:
Despite promising growth prospects, the liquid embolic market faces challenges related to high treatment costs, procedural complexities, and regulatory hurdles. The expensive nature of embolic agents and associated procedural devices limits adoption in cost-sensitive regions. Additionally, the risk of complications such as non-target embolization and the need for specialized training constrain wider usage. Regulatory approval processes for novel embolic materials can be lengthy and stringent, impacting time-to-market for new products.
Market Opportunities:
The liquid embolic market presents significant growth opportunities driven by ongoing research in novel embolic formulations, expansion into emerging markets, and increasing use in peripheral vascular interventions. The integration of digital imaging and navigation technologies enhances procedural accuracy and safety, opening new avenues for market growth. Strategic partnerships between device manufacturers and healthcare providers, along with focused investments in clinical trials and education programs, are essential to leverage these opportunities and sustain competitive advantage in this evolving market.
Key Questions Answered in the Report:
- What are the primary factors driving the growth of the liquid embolic market globally?
- Which types of liquid embolic agents and clinical applications are driving adoption across different healthcare settings?
- How are technological advancements reshaping the competitive landscape of the liquid embolic market?
- Who are the key players contributing to the liquid embolic market, and what strategies are they employing to maintain market relevance?
- What are the emerging trends and future prospects in the global liquid embolic market?
These companies invest heavily in R&D to develop novel embolic materials with enhanced biocompatibility, visibility, and ease of delivery. Collaborations with healthcare institutions and training programs for interventional specialists aid in increasing adoption rates. Moreover, emphasis on clinical trials and regulatory approvals supports market credibility and drives growth in various geographies.
Key Companies Profiled:
- Cerenovus (J&J)
- Medtronic
- Sirtex Medical Inc.
- Terumo Neuro
- Balt
- Meril Life Sciences Pvt. Ltd
- INVAMED
- Peters Surgical
The liquid embolic market encompasses a diverse range of products, technologies, applications, and end-user segments, addressing various vascular disorders and patient populations.
By Product
- Liquid Embolic Vials
- Prefilled Injectables
- Brain Arterio-Venous Malformations (bAVM)
- Tumor Embolization
- Brain Aneurysm
- Dural Arteriovenous Fistulas (dAVFs)
- Others
- Hospitals
- Ambulatory Surgical Centers
- Independent Speciality Centres
- Others
- North America
- Europe
- East Asia
- South Asia and Oceania
- Latin America
- Middle East & Africa
Please Note: It will take 5 business days to complete the report upon order confirmation.
Table of Contents
200 Pages
- 1. Executive Summary
- 1.1. Global Liquid Embolic Market Snapshot, 2025-2032
- 1.2. Market Opportunity Assessment, 2025-2032, US$ Mn
- 1.3. Key Market Trends
- 1.4. Future Market Projections
- 1.5. Premium Market Insights
- 1.6. Industry Developments and Key Market Events
- 1.7. PMR Analysis and Recommendations
- 2. Market Overview
- 2.1. Market Scope and Definition
- 2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Opportunity
- 2.2.4. Key Trends
- 2.3. Macro-Economic Factors
- 2.3.1. Global Sectorial Outlook
- 2.3.2. Global GDP Growth Outlook
- 2.4. COVID-19 Impact Analysis
- 2.5. Forecast Factors - Relevance and Impact
- 3. Value Added Insights
- 3.1. Product Adoption Analysis
- 3.2. Disease Epidemiology - Neurology Disorders
- 3.3. Regulatory Landscape
- 3.4. PESTLE Analysis
- 3.5. Porter’s Five Force Analysis
- 3.6. Promotional Strategies, By Key Players
- 4. Global Liquid Embolic Market Outlook
- 4.1. Key Highlights
- 4.1.1. Market Size (US$ Mn) and Y-o-Y Growth
- 4.1.2. Absolute $ Opportunity
- 4.2. Market Size (US$ Mn) Analysis and Forecast
- 4.2.1. Historical Market Size (US$ Mn) Analysis, 2019-2024
- 4.2.2. Market Size (US$ Mn) Analysis and Forecast, 2025-2032
- 4.3. Global Liquid Embolic Market Outlook: Product
- 4.3.1. Introduction / Key Findings
- 4.3.2. Historical Market Size (US$ Mn) Analysis, By Product, 2019-2024
- 4.3.3. Market Size (US$ Mn) Analysis and Forecast, By Product, 2025-2032
- 4.3.3.1. Liquid Embolic Vials
- 4.3.3.2. Prefilled Injectables
- 4.3.4. Market Attractiveness Analysis: Product
- 4.4. Global Liquid Embolic Market Outlook: Indication
- 4.4.1. Introduction / Key Findings
- 4.4.2. Historical Market Size (US$ Mn), By Indication, 2019-2024
- 4.4.3. Market Size (US$ Mn) Analysis and Forecast, By Indication, 2025-2032
- 4.4.3.1. Brain Arterio-Venous Malformations (bAVM)
- 4.4.3.2. Tumor Embolization
- 4.4.3.3. Brain Aneurysm
- 4.4.3.4. Dural Arteriovenous Fistulas (dAVFs)
- 4.4.3.5. Others
- 4.4.4. Market Attractiveness Analysis: Indication
- 4.5. Global Liquid Embolic Market Outlook: End User
- 4.5.1. Introduction / Key Findings
- 4.5.2. Historical Market Size (US$ Mn), By End User, 2019-2024
- 4.5.3. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
- 4.5.3.1. Hospitals
- 4.5.3.2. Ambulatory Surgical Centers (ASCs)
- 4.5.3.3. Independent Specialty Centers
- 4.5.3.4. Others
- 4.5.4. Market Attractiveness Analysis: End User
- 5. Global Liquid Embolic Market Outlook: Region
- 5.1. Key Highlights
- 5.2. Historical Market Size (US$ Mn) Analysis, By Region, 2019-2024
- 5.3. Market Size (US$ Mn) Analysis and Forecast, By Region, 2025-2032
- 5.3.1. North America
- 5.3.2. Europe
- 5.3.3. East Asia
- 5.3.4. South Asia and Oceania
- 5.3.5. Latin America
- 5.3.6. Middle East & Africa
- 5.4. Market Attractiveness Analysis: Region
- 6. North America Liquid Embolic Market Outlook
- 6.1. Key Highlights
- 6.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
- 6.2.1. By Country
- 6.2.2. By Product
- 6.2.3. By Indication
- 6.2.4. By End User
- 6.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
- 6.3.1. U.S.
- 6.3.2. Canada
- 6.4. Market Size (US$ Mn) Analysis and Forecast, By Product, 2025-2032
- 6.4.1. Liquid Embolic Vials
- 6.4.2. Prefilled Injectables
- 6.5. Market Size (US$ Mn) Analysis and Forecast, By Indication, 2025-2032
- 6.5.1. Brain Arterio-Venous Malformations (bAVM)
- 6.5.2. Tumor Embolization
- 6.5.3. Brain Aneurysm
- 6.5.4. Dural Arteriovenous Fistulas (dAVFs)
- 6.5.5. Others
- 6.6. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
- 6.6.1. Hospitals
- 6.6.2. Ambulatory Surgical Centers (ASCs)
- 6.6.3. Independent Specialty Centers
- 6.6.4. Others
- 6.7. Market Attractiveness Analysis
- 7. Europe Liquid Embolic Market Outlook
- 7.1. Key Highlights
- 7.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
- 7.2.1. By Country
- 7.2.2. By Product
- 7.2.3. By Indication
- 7.2.4. By End User
- 7.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
- 7.3.1. Germany
- 7.3.2. France
- 7.3.3. U.K.
- 7.3.4. Italy
- 7.3.5. Spain
- 7.3.6. Russia
- 7.3.7. Turkey
- 7.3.8. Rest of Europe
- 7.4. Market Size (US$ Mn) Analysis and Forecast, By Product, 2025-2032
- 7.4.1. Liquid Embolic Vials
- 7.4.2. Prefilled Injectables
- 7.5. Market Size (US$ Mn) Analysis and Forecast, By Indication, 2025-2032
- 7.5.1. Brain Arterio-Venous Malformations (bAVM)
- 7.5.2. Tumor Embolization
- 7.5.3. Brain Aneurysm
- 7.5.4. Dural Arteriovenous Fistulas (dAVFs)
- 7.5.5. Others
- 7.6. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
- 7.6.1. Hospitals
- 7.6.2. Ambulatory Surgical Centers (ASCs)
- 7.6.3. Independent Specialty Centers
- 7.6.4. Others
- 7.7. Market Attractiveness Analysis
- 8. East Asia Liquid Embolic Market Outlook
- 8.1. Key Highlights
- 8.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
- 8.2.1. By Country
- 8.2.2. By Product
- 8.2.3. By Indication
- 8.2.4. By End User
- 8.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
- 8.3.1. China
- 8.3.2. Japan
- 8.3.3. South Korea
- 8.4. Market Size (US$ Mn) Analysis and Forecast, By Product, 2025-2032
- 8.4.1. Liquid Embolic Vials
- 8.4.2. Prefilled Injectables
- 8.5. Market Size (US$ Mn) Analysis and Forecast, By Indication, 2025-2032
- 8.5.1. Brain Arterio-Venous Malformations (bAVM)
- 8.5.2. Tumor Embolization
- 8.5.3. Brain Aneurysm
- 8.5.4. Dural Arteriovenous Fistulas (dAVFs)
- 8.5.5. Others
- 8.6. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
- 8.6.1. Hospitals
- 8.6.2. Ambulatory Surgical Centers (ASCs)
- 8.6.3. Independent Specialty Centers
- 8.6.4. Others
- 8.7. Market Attractiveness Analysis
- 9. South Asia & Oceania Liquid Embolic Market Outlook
- 9.1. Key Highlights
- 9.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
- 9.2.1. By Country
- 9.2.2. By Product
- 9.2.3. By Indication
- 9.2.4. By End User
- 9.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
- 9.3.1. India
- 9.3.2. Southeast Asia
- 9.3.3. ANZ
- 9.3.4. Rest of South Asia & Oceania
- 9.4. Market Size (US$ Mn) Analysis and Forecast, By Product, 2025-2032
- 9.4.1. Liquid Embolic Vials
- 9.4.2. Prefilled Injectables
- 9.5. Market Size (US$ Mn) Analysis and Forecast, By Indication, 2025-2032
- 9.5.1. Brain Arterio-Venous Malformations (bAVM)
- 9.5.2. Tumor Embolization
- 9.5.3. Brain Aneurysm
- 9.5.4. Dural Arteriovenous Fistulas (dAVFs)
- 9.5.5. Others
- 9.6. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
- 9.6.1. Hospitals
- 9.6.2. Ambulatory Surgical Centers (ASCs)
- 9.6.3. Independent Specialty Centers
- 9.6.4. Others
- 9.7. Market Attractiveness Analysis
- 10. Latin America Liquid Embolic Market Outlook
- 10.1. Key Highlights
- 10.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
- 10.2.1. By Country
- 10.2.2. By Product
- 10.2.3. By Indication
- 10.2.4. By End User
- 10.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
- 10.3.1. Brazil
- 10.3.2. Mexico
- 10.3.3. Rest of Latin America
- 10.4. Market Size (US$ Mn) Analysis and Forecast, By Product, 2025-2032
- 10.4.1. Liquid Embolic Vials
- 10.4.2. Prefilled Injectables
- 10.5. Market Size (US$ Mn) Analysis and Forecast, By Indication, 2025-2032
- 10.5.1. Brain Arterio-Venous Malformations (bAVM)
- 10.5.2. Tumor Embolization
- 10.5.3. Brain Aneurysm
- 10.5.4. Dural Arteriovenous Fistulas (dAVFs)
- 10.5.5. Others
- 10.6. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
- 10.6.1. Hospitals
- 10.6.2. Ambulatory Surgical Centers (ASCs)
- 10.6.3. Independent Specialty Centers
- 10.6.4. Others
- 10.7. Market Attractiveness Analysis
- 11. Middle East & Africa Liquid Embolic Market Outlook
- 11.1. Key Highlights
- 11.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
- 11.2.1. By Country
- 11.2.2. By Product
- 11.2.3. By Indication
- 11.2.4. By End User
- 11.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
- 11.3.1. GCC Countries
- 11.3.2. Egypt
- 11.3.3. South Africa
- 11.3.4. Northern Africa
- 11.3.5. Rest of Middle East & Africa
- 11.4. Market Size (US$ Mn) Analysis and Forecast, By Product, 2025-2032
- 11.4.1. Liquid Embolic Vials
- 11.4.2. Prefilled Injectables
- 11.5. Market Size (US$ Mn) Analysis and Forecast, By Indication, 2025-2032
- 11.5.1. Brain Arterio-Venous Malformations (bAVM)
- 11.5.2. Tumor Embolization
- 11.5.3. Brain Aneurysm
- 11.5.4. Dural Arteriovenous Fistulas (dAVFs)
- 11.5.5. Others
- 11.6. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
- 11.6.1. Hospitals
- 11.6.2. Ambulatory Surgical Centers (ASCs)
- 11.6.3. Independent Specialty Centers
- 11.6.4. Others
- 11.7. Market Attractiveness Analysis
- 12. Competition Landscape
- 12.1. Market Share Analysis, 2025
- 12.2. Market Structure
- 12.2.1. Competition Intensity Mapping By Market
- 12.2.2. Competition Dashboard
- 12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
- 12.3.1. Cerenovus (J&J)
- 12.3.1.1. Overview
- 12.3.1.2. Segments and Products
- 12.3.1.3. Key Financials
- 12.3.1.4. Market Developments
- 12.3.1.5. Market Strategy
- 12.3.2. Medtronic
- 12.3.3. Sirtex Medical Inc.
- 12.3.4. Terumo Neuro
- 12.3.5. Balt
- 12.3.6. Meril Life Sciences Pvt. Ltd
- 12.3.7. INVAMED
- 12.3.8. Peters Surgical
- 13. Appendix
- 13.1. Research Methodology
- 13.2. Research Assumptions
- 13.3. Acronyms and Abbreviations
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.